Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.
Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.
复制标题
DOI:
10.1086/652864
复制
发表时间:
2010-06-15
期刊:
影响因子:
--
通讯作者:
Campa A
中科院分区:
文献类型:
--
作者:
Baum MK;Lai S;Sales S;Page JB;Campa A
Adequate zinc is critical for immune function; however, zinc deficiency occurs in >50% of HIV-infected adults. We examined the safety and efficacy of long-term zinc supplementation on HIV disease progression. A prospective randomized controlled clinical trial was conducted with 231 HIV+ adults with low plasma zinc levels (<0.75 μg/ml), randomly assigned into zinc (12 mg of elemental zinc for women and 15 mg for men) or placebo, for 18 months. The primary endpoint was immunological failure. HIV-viral load and CD4+ cell count were determined every 6 months. Questionnaires, pill-counts, plasma zinc and C-reactive protein (hsCRP) were used to monitor adherence with study supplements and ART. Intent-to-treat analysis utilized multiple-event analysis, treating CD4+ cell count <200 cells/mm3 as recurrent immunological failure event. Cox proportional-hazard models and the general-linear model were used to analyze morbidity and mortality data. Zinc supplementation for 18 months reduced four-fold the likelihood of immunological failure, controlling for age, gender, lack of food, baseline CD4+ cell count, viral load, and antiretroviral therapy (RR=0.24[95%CI:0.10,0.56],p<0.002). Viral load indicated poor control with ART but was not affected by zinc supplementation. Zinc supplementation also reduced the rate of diarrhea by more than half (OR=0.4[95%CI:0.183-0.981],p=0.019) compared to placebo. There was no significant difference in mortality between the two groups. This study demonstrated that long-term (18-month) zinc supplementation at nutritional levels delayed immunological failure and decreased diarrhea over time. This evidence supports the use of zinc supplementation as an adjunct therapy in HIV+ adult cohorts with poor viral control. This study demonstrated that long-term (18-month) zinc supplementation at nutritional levels delayed immunological failure and decreased diarrhea over time. This evidence supports the use of zinc supplementation as an adjunct therapy in HIV+ adult cohorts with poor viral control.
登录
查看更多内容
DOI:
10.1097/qai.0b013e31817bebb3
发表时间:
2008-08-15
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Baker JV;Peng G;Rapkin J;Krason D;Reilly C;Cavert WP;Abrams DI;MacArthur RD;Henry K;Neaton JD;Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
通讯作者:
Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
影响因子:
3.8
作者:
BAUM, MK;SHORPOSNER, G;HENNEKENS, CH
通讯作者:
HENNEKENS, CH
影响因子:
4.2
作者:
Baum, MK;Shor-Posner, G;Campa, A
通讯作者:
Campa, A
DOI:
10.1097/01.qai.0000182847.38098.d1
发表时间:
2005-11-01
影响因子:
3.6
作者:
Moore, DM;Hogg, RS;Montaner, JSG
通讯作者:
Montaner, JSG
影响因子:
1
作者:
Gutierrez, Felix;Padilla, Sergio;del Amo, Julia
通讯作者:
del Amo, Julia